Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Post by donkeyfeatherson May 17, 2022 9:48am
228 Views
Post# 34688884

A Match Made in Heaven

A Match Made in HeavenCD at Evotec certainly impressed me with that comment.  I also liked the answers given to Doug Lowes questions - straightforward: we have the bench science and the data to move this partnership along quickly.  Watching the trades go through now and keeping a close eye on whether the price can be kept above $1.72, so some of those warrants are kept in the money and then must be exercised. I'm still holding my timeline for significant multiples, assuming the CC progress continues and the IND submission doesn't hit a snag.  Based on earnings potential, the TSX uplist appears to be just a matter of formalities being addressed.  Congrats to all who worked on getting this partnership realised, and most of all, thinking about Dr. White's visionary thinking way back when :) 
DF
<< Previous
Bullboard Posts
Next >>